| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/10/1997 | US5637690 Sulfate of n-acetylneuraminic acid homopolymer and processes for making and using the same |
| 06/10/1997 | US5637684 Phosphoramidate and phosphorothioamidate oligomeric compounds |
| 06/10/1997 | US5637625 Phospholipid coatings; extended shelf life |
| 06/10/1997 | US5637624 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
| 06/10/1997 | US5637623 Substituted adamantyl guanidines and methods of use there of |
| 06/10/1997 | US5637622 Nervous system disorders |
| 06/10/1997 | US5637620 Micro formoterol particles |
| 06/10/1997 | US5637619 Antitumor 2-aminocarbonyl-1, 2-bis(methylsulfonyl)-1-(substituted)hydrazines |
| 06/10/1997 | US5637617 Methods for use of GABAa receptor GABAergic compounds |
| 06/10/1997 | US5637616 Method for treating diseases mediated by proteases |
| 06/10/1997 | US5637615 Antiaging agent |
| 06/10/1997 | US5637614 Immunomodulator |
| 06/10/1997 | US5637613 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 06/10/1997 | US5637612 Mixture with dipeptidase inhibitor |
| 06/10/1997 | US5637611 Vasoconstructive agents; migraine |
| 06/10/1997 | US5637610 Composition containing dioxabicyclo [3.3.0] octane derivative |
| 06/10/1997 | US5637609 2-phenylpyrrole derivatives as dopamine D3 receptor antagonists |
| 06/10/1997 | US5637608 Photodynamic therapy |
| 06/10/1997 | US5637606 Hair grower based on allantoin or derivatives thereof |
| 06/10/1997 | US5637605 α-fluoro-α-1-(1,2,4-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors |
| 06/10/1997 | US5637604 Treatment and control of ocular development |
| 06/10/1997 | US5637603 Use of disulfonyl methanes and anthelmintics for the control of parasites |
| 06/10/1997 | US5637602 Nervous system disorders; gastrointestinal disorders |
| 06/10/1997 | US5637600 Phenylpyrrole derivatives and their use as dopamine D3 antagonists |
| 06/10/1997 | US5637598 Methods of inhibiting bone loss |
| 06/10/1997 | US5637597 Carbostyril derivatives for inhibiting production of interleukin-8 |
| 06/10/1997 | US5637596 Reacting aminomethylindole derivative with a carbonyl containing cyclizing agent; 5-ht3 receptor atagonist; useful for treating anxiety, psychosis, gut motility disorder, emesis, migraine and drug addiction |
| 06/10/1997 | US5637594 Antimalarial synergistic compositions containing benflumetol |
| 06/10/1997 | US5637593 Tryptamine analogues as 5-ht1-like agonists |
| 06/10/1997 | US5637592 Treating helicobacter infections, such as gastritis, stomach ulcers, duodenal ulcers and gastric cancer |
| 06/10/1997 | US5637591 Antimicrobial and anticollagenase activity of phenazine-5, 10-dioxide and derivatives |
| 06/10/1997 | US5637590 Rapamycin amidino carbamates |
| 06/10/1997 | US5637586 Angiotensin inhibitor; hypotensive agent |
| 06/10/1997 | US5637582 Peripheral circulation improving agent |
| 06/10/1997 | US5637581 Preparations containing 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines |
| 06/10/1997 | US5637580 Antimicrobial penem-quinolones |
| 06/10/1997 | US5637579 Beta-lactamase inhibitors; bactericides |
| 06/10/1997 | US5637578 Agents for inflammation, ischemic/reperfusion injury, stroke, atherosclerosis, and hypertension |
| 06/10/1997 | US5637577 Treatment of potozoal diseases |
| 06/10/1997 | US5637576 Administering oligosaccharide sequence covalently attached to solid support |
| 06/10/1997 | US5637575 Orally administering liquid composition comprising water soluble sulfated cyclodextrin derivative and nontoxic carrier |
| 06/10/1997 | US5637574 Therapeutic nucleosides |
| 06/10/1997 | US5637572 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 06/10/1997 | US5637571 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis |
| 06/10/1997 | US5637459 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 06/10/1997 | US5637322 Method for producing composition for solid medicine |
| 06/10/1997 | US5637320 Controlled absorption naproxen formulation for once-daily administration |
| 06/10/1997 | US5637318 Increased oxygen penetration of skin |
| 06/10/1997 | US5637315 Intravenously administering free radical scavenger or antioxidant selected from alpha-tocopherol, ascorbic acid 6-palmitate, dihydrolipoic acid, butylated hydroxytoluene and a liposome carrier |
| 06/10/1997 | US5637314 Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
| 06/10/1997 | US5637313 Matrix of starch hydrolysate and mixture of a water soluble and water insoluble bulking agent |
| 06/10/1997 | US5637311 Zinc(II) complexes and methods related thereto |
| 06/10/1997 | US5637310 Method of treating prostatic adenocarcinoma |
| 06/10/1997 | US5637305 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 06/10/1997 | US5637304 Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use |
| 06/10/1997 | US5637302 Solvent extraction from leaves |
| 06/10/1997 | US5637293 Stability; discoloration inhibition; mixture of kojic acid, ultraviolet radiation absorber, fatty ester and(or) glyceride |
| 06/10/1997 | US5637291 Acrylonitrile polymer |
| 06/10/1997 | US5637085 Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site |
| 06/10/1997 | CA2109958C Calcium, trace mineral, vitamin d and drug therapy combinations |
| 06/10/1997 | CA2106216C Chewable antacid compositions |
| 06/10/1997 | CA2074876C Condensed naphthyridine derivatives |
| 06/10/1997 | CA2059510C Use of nadh and nadph as energy substitutes |
| 06/10/1997 | CA2028725C Polymer mixtures useful in skin care |
| 06/09/1997 | CA2192283A1 Prolactin production inhibitory agent |
| 06/09/1997 | CA2190708A1 Aminoalkyl substituted benzo-heterocyclic compounds |
| 06/09/1997 | CA2190699A1 Tertiary amines |
| 06/08/1997 | CA2192298A1 Neuroprotective agents |
| 06/08/1997 | CA2192044A1 Amidinohydrazones of ketones derived from benzo[b]furan, processes for their production, and pharmaceuticals containing these compounds |
| 06/07/1997 | CA2192228A1 Pharmaceutical compositions based on mequitazine |
| 06/06/1997 | CA2191924A1 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production |
| 06/05/1997 | WO1997020212A1 Treatment of inflammation by inhibition of lipid body formation |
| 06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
| 06/05/1997 | WO1997020060A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | WO1997020059A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 06/05/1997 | WO1997020052A1 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
| 06/05/1997 | WO1997020050A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | WO1997020047A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | WO1997019956A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/05/1997 | WO1997019954A1 Targeted cytotoxic anthracycline analogs |
| 06/05/1997 | WO1997019953A2 New lh-rh antagonists with improved effectiveness |
| 06/05/1997 | WO1997019947A1 2'-[[4'-HALO-[1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO[CYCLOPENTANE-1,7'(8'H)-[3H]IMIDAZO[2,1-b]PURIN]-4'(5'H)-ONES |
| 06/05/1997 | WO1997019946A1 Pyridopyrimidines |
| 06/05/1997 | WO1997019942A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 06/05/1997 | WO1997019940A1 Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
| 06/05/1997 | WO1997019932A1 2-thioxo-imidazolidin-4-one derivatives and their use for increasing hdl cholesterol concentration |
| 06/05/1997 | WO1997019931A1 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives |
| 06/05/1997 | WO1997019929A1 Polycyclic compounds |
| 06/05/1997 | WO1997019928A1 Salts of quinoline derivatives as nk3 antagonists |
| 06/05/1997 | WO1997019927A1 Quinoline derivatives as nk3 antagonists |
| 06/05/1997 | WO1997019926A1 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 (nk-3)- and neurokinin 2 (nk-2) receptor antagonists. |
| 06/05/1997 | WO1997019925A1 Quinoline derivatives containing a diol as leukotriene antagonists |
| 06/05/1997 | WO1997019918A1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof |
| 06/05/1997 | WO1997019914A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 06/05/1997 | WO1997019913A1 Amino acid derivatives, medicaments containing said compounds and methods of producing them |
| 06/05/1997 | WO1997019909A1 Amino alcohol derivatives, methods of producing said derivatives and medicaments containing them |
| 06/05/1997 | WO1997019724A1 Hollow-tube brachytherapy device |
| 06/05/1997 | WO1997019703A2 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
| 06/05/1997 | WO1997019702A2 Powdery iodine complexes |